{"indexed":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T12:31:19Z","timestamp":1653049879444},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1038\/nrd842","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T21:36:31Z","timestamp":1027892191000},"page":"491-492","source":"Crossref","is-referenced-by-count":59,"title":"Selective anticancer drugs","prefix":"10.1038","volume":"1","author":[{"given":"Joshua H.","family":"Atkins","sequence":"first","affiliation":[]},{"given":"Leland J.","family":"Gershell","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnrd842_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd839","volume":"1","author":"R Capdeville","year":"2002","unstructured":"Capdeville, R. et al. Glivec (STI571, imatinib), a rationally developed targeted anticancer drug. Nature Rev. Drug Discov. 1, 493\u2013502 (2002).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrd842_CR2","first-page":"2958","volume":"7","author":"F Ciardello","year":"2001","unstructured":"Ciardello, F. & Tortora, G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin. Cancer Res. 7, 2958\u20132970 (2001).","journal-title":"Clin. Cancer Res."},{"key":"BFnrd842_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1535-6108(02)00039-9","volume":"1","author":"LK Shawver","year":"2002","unstructured":"Shawver, L. K., Slamon, D. & Ullrich, A. Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1, 117\u2013123 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrd842_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","volume":"52","author":"A Jem","year":"2002","unstructured":"Jem, A. et al. Cancer statistics, 2002. CA Cancer J. Clin. 52, 23\u201347 (2002)","journal-title":"CA Cancer J. Clin."}],"container-title":"Nature Reviews Drug Discovery","original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrd842.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd842","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd842.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T09:28:59Z","timestamp":1638437339000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/articles\/nrd842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":4,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["BFnrd842"],"URL":"http:\/\/dx.doi.org\/10.1038\/nrd842","relation":{},"ISSN":["1474-1776","1474-1784"],"subject":["Drug Discovery","Pharmacology","General Medicine"],"container-title-short":"Nat Rev Drug Discov","published":{"date-parts":[[2002,7]]}}